| Literature DB >> 36129950 |
Sarah C Leighton1, Leanne O Nieforth2, Marguerite E O'Haire2.
Abstract
Psychiatric assistance dogs for military veterans with posttraumatic stress disorder (PTSD) currently make up over 19% of assistance dog partnerships globally. We conducted a systematic review of the literature relating to these partnerships, with specific aims to (1) summarize their characteristics, (2) evaluate the quality of existing evidence, and (3) summarize outcomes. A total of 432 records were independently screened (Cohen's kappa = 0.90). Of these, 41 articles (29 peer-reviewed publications and 12 unpublished dissertations) met inclusion criteria. Data extraction was conducted to address the research aims, including a meta-analysis (quantitative outcomes) and meta-synthesis (qualitative outcomes). All peer-reviewed publications on the topic of psychiatric assistance dogs for veterans with PTSD were published within the last five years. The majority of included articles were quantitative (53%), 41% were qualitative, and 6% employed mixed methods. Mean methodological rigor scores were 80% for peer reviewed articles and 71% for dissertations, where higher scores represent more rigorous methodology. Quantitative articles reported significant improvements in the domains of PTSD severity, mental health, and social health. Impacts on physical health and global quality of life appear inconclusive. Meta-analysis (9 articles) revealed that partnership with an assistance dog had a clinically meaningful, significant, and large effect on PTSD severity scores (g = -1.129; p<0.0001). Qualitative meta-synthesis identified two third order constructs: (1) Impact on the individual: mental & physical health and (2) Impact beyond the individual: building relationships & connection. This synthesis of increasingly prevalent research on assistance dogs for veterans with PTSD provides support for the impact of this complementary and integrative health intervention on PTSD symptom severity, and signs of meaningful improvements in adjacent domains including mental and social health. Gaps between quantitative and qualitative findings, along with the need to report greater demographic detail, highlight key opportunities for future research.Entities:
Mesh:
Year: 2022 PMID: 36129950 PMCID: PMC9491613 DOI: 10.1371/journal.pone.0274960
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.752
Fig 1Study identification and screening for inclusion in systematic review and meta-analysis.
Fig 2Dissertations (n = 12) and peer-reviewed publications (n = 29) relating to service dogs and veterans with PTSD by year.
Non-veteran participant studies: Participants, design, and outcomes.
| Study | Participants (n) | Design | Outcomes |
|---|---|---|---|
|
| |||
| Woodward 2021 | Veterans training SDs, inpatient program (54) | Repeated measures (ABAB) | |
| van Houtert 2021 | SDs (19) | Cross-sectional | |
| Whitworth 2020 | Partners of veterans in SD training program (15) | Qualitative | |
| McCall 2020 | Partners of veterans with SDs (37) and on WL (23) | Cross-sectional + Qualitative | |
| Vincent 2017a | SD trainers (12) | Qualitative | |
|
| |||
| Genbauffe 2020 | Psychotherapists (3) | Qualitative | |
| Tilvaldiev 2019 | SD trainers (11) | Qualitative |
Notes. Ordered in reverse chronological order within each category (peer-reviewed, dissertation). SD service dog. WL waitlist to receive service dog. PCL-5 PTSD Checklist for DSM-5.✓ Positive outcome; ⎯ Neutral or null outcome; ✘ Negative outcome; ● Theory-based framework or protocol result. ↑ increased; ↓ decreased.
Study characteristics.
| Study | Design | Control | N | PTSD Measure | Outcomes |
|---|---|---|---|---|---|
|
| |||||
| Jensen (2021) | Cross-sectional | WL | 186 | PCL-5 ✓ | |
| Nieforth (2021a) | Qualitative | - | 101 | CAPS-5 | |
| Nieforth (2021b) | Qualitative | WL | 128 | PCL-C | |
| Rodriguez (2021) | Cross-sectional | WL | 96 | PCL-C ✗ | |
| Williamson (2021) | Single subject (AB) + Qualitative | Pre-Post (12m) | 5 | PCL-5 ✓ | |
| Galsgaard (2020) | Single subject (AB) | Pre-Post (16m) | 4 | PCL-C | |
| Husband (2020) | Qualitative | - | 4 | - | |
| Lessard (2020) | Pre-post | Pre-Post (9m) | 18 | PCL-M ✓ | |
| Richerson (2020) | Randomized control | ESA | 227 | CAPS-5 | |
| Rodriguez (2020) | Cross-sectional | WL | 217 | PCL-5 ✓ | |
| Lafollette (2019) | Cross-sectional | - | 111 | PCL-5 ✓ | |
| McLaughlin (2019) | Qualitative | - | 7 | - | |
| Scotland-Coogan (2019a) | Qualitative | - | 15 | - | |
| Scotland-Coogan (2019b) | Qualitative | - | 15 | - | |
| Whitworth (2019) | Non-randomized control | WL | 30 | TSI-2 | |
| Crowe (2018a) | Qualitative | - | 9 | - | |
| Crowe (2018b) | Qualitative | - | 6 | - | |
| Lessard (2018) | Qualitative | - | 10 | - | |
| O’Haire (2018) | Non-randomized control | WL | 141 | PCL-C ✗ | |
| Rodriguez (2018) | Cross-sectional | WL | 73 | PCL-C ✓ | |
| Yarborough (2018) | Qualitative | - | 55 | Clinician report | |
| Kloep (2017) | Pre-post | Pre-Post (6m) | 13 | PCL-S ✓ | |
| Vincent (2017b) | Pre-post | Pre-Post (3m) | 15 | PCL-M ✓ | |
| Yarborough (2017) | Cross-sectional | WL | 78 | PCL-C ✓ | |
|
| |||||
| Floore-Guetschow (2020) | Qualitative | - | 7 | - | |
| Hansen (2019) | Cross-sectional | Combat vs. non-combat | 64 | PCL-5 | |
| Parenti (2019) | Repeated measures (ABCDE) | Dog (SD / pet) present / absent | 6 | PCL-5 | |
| Kegel (2016) | Cross-sectional | V | 66 | PCL-M | |
| Kopicki (2016) | Cross-sectional | WL | 18 | PCL-M | |
| Brown (2015) | Qualitative | - | 1 | - | |
| Hyde (2015) | Cross-sectional + Qualitative | - | 7 | PCL-5 | ✓ ↑ hope, social and community engagement, routine. |
| Marston (2015) | Cross-sectional | WL | 18 | - | |
| Moore (2014) | Qualitative | - | 8 | - | |
| Newton (2014) | Qualitative | - | 6 | - | |
Notes. Ordered by most recent to least recent within each group. SD Veterans with service dogs. WL Waitlist to receive service dog. ES Emotional support dog. Pre Pre-placement. V Veterans not on waitlist nor partnered with service dog. P Partner. T Service dog trainer. PCL PTSD Checklist (-C Civilian; -M Military; -S Specific; -5 for DSM-5). CAPS Clinician-Administered PTSD Scale. TSI-2 Trauma Symptom Inventory-2. PCL ✓ Clinically significant improvement in mean score; PCL ✗ Mean score change not clinically significant; Italics indicates time points. No symbol: Mean score change not reported. ✓ Positive outcome; ⎯ Neutral or null outcome; ✘ Negative outcome. ↑ increased; ↓ decreased. QoL Quality of Life. DUSI-R SU Drug Use Screening Inventory Revised Substance Use Subscale. +R Positive reinforcement. +P Positive punishment.
aChallenges in public may include access issues, stigma, and unwanted attention.
Participant characteristics.
| Study | Age, | % Male | Secondary Disabilities Assessed | Medications and Treatments | United States Military Branch (%) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TBI | SUD | Psy | Phy | A | AF | CG | MC | N | NG | ||||
|
| |||||||||||||
| Jensen 2021 | 40 | 74 | - | TAU | - | ||||||||
| Nieforth 2021a | - | 79 | - | TAU | - | ||||||||
| Nieforth 2021b | 38 | 80 | ✓ | TAU | 65 | 12 | 0 | 12 | 12 | 0 | |||
| Rodriguez 2021 | 39 | 78 | - | M: 74%; T: 82% | - | ||||||||
| Williamson 2021 | 43 | 100 | ✓ | M: 100% T: TAU | Not USA | ||||||||
| Galsgaard 2020 | 48 | 100 | ✓ | M:—T: 100% | Not USA | ||||||||
| Husband 2020 | - | 75 | - | M: 100%; T: - | Not USA | ||||||||
| Lessard 2020 | 50 | 83 | - | M: -; T: 88% | Not USA | ||||||||
| Richerson 2020 | 50 | 78 | ✓ | ✓ | M: -; T: 100% | 53 | 10 | 2 | 20 | 16 | 11 | ||
| Rodriguez 2020 | 40 | 75 | - | TAU | - | ||||||||
| Lafollette 2019 | 40 | 80 | - | - | - | ||||||||
| McLaughlin 2019 | - | 86 | - | - | Not USA | ||||||||
| Scotland-Coogan 2019a | - | - | - | - | - | ||||||||
| Scotland-Coogan 2019b | - | - | - | - | - | ||||||||
| Whitworth 2019 | 51 | 87 | - | M: 93%; T: 90% | 57 | 3 | 3 | 13 | 23 | 0 | |||
| Crowe 2018a | 36 | 100 | - | M: -; T: 100% | 56 | 11 | 0 | 33 | 11 | 0 | |||
| Crowe 2018b | 43 | 67 | ✓ | M: 100%; T: 100% | 83 | 17 | 0 | 17 | 0 | 0 | |||
| Lessard 2018 | - | 90 | - | - | Not USA | ||||||||
| O’Haire 2018 | 37 | 78 | ✓ | ✓ | M: TAU; T: 79% | 66 | 10 | 0 | 11 | 13 | 0 | ||
| Rodriguez 2018 | 37 | 81 | ✓ | M: -; T: 79% | 56 | 12 | 0 | 12 | 19 | 0 | |||
| Yarborough 2018 | 45 | 68 | - | M: 64%; T: - | - | ||||||||
| Kloep 2017 | 38 | 69 | ✓ | ✓ | M: 100%; T: 100% | - | |||||||
| Vincent 2017b | - | 75 | - | - | Not USA | ||||||||
| Yarborough 2017 | 42 | 69 | - | M: 70% T: - | - | ||||||||
|
| |||||||||||||
| Floore-Guetschow 2020 | - | 43 | - | - | 43 | 14 | 0 | 29 | 29 | 0 | |||
| Hansen 2019 | - | 69 | ✓ | - | - | ||||||||
| Parenti 2019 | - | 100 | - | - | - | ||||||||
| Kegel 2016 | - | 58 | ✓ | ✓ | - | - | |||||||
| Kopicki 2016 | 39 | 74 | ✓ | - | 65 | 25 | 0 | 20 | 10 | 0 | |||
| Brown 2015 | - | 100 | - | - | - | ||||||||
| Hyde 2015 | 44 | 100 | ✓ | - | - | ||||||||
| Marston 2015 | 39 | 74 | ✓ | - | 65 | 25 | 0 | 20 | 10 | 0 | |||
| Moore 2014 | - | 75 | ✓ | ✓ | M: -; T: 100% | 50 | 13 | 0 | 13 | 25 | 0 | ||
| Newton 2014 | - | 83 | ✓ | - | - | ||||||||
Notes. Ordered by most to least recent within each group.—Not reported. TBI Traumatic Brain Injury. SUD Substance use disorder. Psy Psychiatric disability (other than PTSD). Phy Physical disability. M Medication. T Treatment. TAU Treatment as usual. A Army. AF Air Force. CG Coast Guard. MC Marine Corps. N Navy. NG National Guard.
sRequirement of study.
pRequirement of program.
aMay exceed 100% if participants served with multiple branches.
Fig 3Number of studies (n = 18) reporting PTSD-specific trained tasks.
Fig 4Number of quantitative studies (n = 20) meeting each rigor criterion, where applicable.
Fig 5Number of qualitative studies (n = 16) meeting each rigor criterion, where applicable.
Fig 6Forest plot on impact of service dog placement on PTSD checklist for DSM-5 (PCL-5) scores for veterans with PTSD.
PCL-5 scores for studies included in meta-analysis.
| Study | No Dog | Dog | Δ M | Rigor | |||
|---|---|---|---|---|---|---|---|
| Control | n | n | |||||
| Kloep 2017 | Pre | 52.00 (12.5) | 12 | 15.00 (7.5) | 12 | -37.00 | 93% |
| Vincent 2017b | Pre | 61.00 (10.0) | 19 | 40.00 (16.5) | 19 | -21.00 | 53% |
| Lessard 2018 | Pre | 56.00 (12.0) | 15 | 35.00 (16.5) | 15 | -21.00 | 87% |
| Richerson 2020 | Pre | 48.33 (15.7) | 97 | 31.66 (14.6) | 88 | -16.67 | 93% |
| Yarborough 2017 | WL | 56.00 (14.5) | 51 | 38.00 (22.0) | 22 | -18.00 | 93% |
| Jensen 2021 | WL | 58.97 (13.0) | 74 | 44.34 (17.1) | 112 | -14.63 | 93% |
| O’Haire 2018 | WL | 56.00 (14.5) | 66 | 46.00 (16.0) | 74 | -10.00 | 100% |
| Williamson 2021 | Pre | 60.20 (14.5) | 5 | 48.10 (19.2) | 5 | -12.10 | 82% |
| Galsgaard 2020 | Pre | 45.00 (15.5) | 4 | 34.00 (14.5) | 4 | -11.00 | 55% |
|
|
|
|
|
|
| ||
Notes. Order corresponds to Fig 6, i.e., according to effect size (Hedge’s g).
* Scores crosswalked from PCL-C, -M, or -S for comparability to PCL-5. WL Veterans on a waitlist to receive a service dog. Pre Baseline timepoint prior to placement with a service dog.
A change in PCL-5 score of 10 or more indicates clinically meaningful change; a score of 33 or higher is considered indicative of a PTSD diagnosis.